Prohibited substance case under FEI anti-doping rules  

24 Jul 2018

The FEI has today announced an adverse analytical finding (AAF) involving an equine prohibited substance.

The case involves a *Banned Substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).

The athlete has been provisionally suspended from the date of notification until the FEI Tribunal renders its decisions. The horse has been provisionally suspended for two months:

Horse: Fifty Shades (FEI ID 104ZG11/USA)

Person Responsible: Andrea Torres Guerreiro (FEI ID 10114368/COL)

Event: CSI4* - Tryon NC (USA), 5-10.06.2018

Prohibited Substance(s): Boldenone, Boldenone Sulfate

Date of notification: 23 July 2018


Details on this case can be found here.


Notes to Editors


FEI Equine Prohibited Substances

The FEI Prohibited Substances List is divided into two sections: Controlled Medication and *Banned Substances. Controlled Medication substances are those that are regularly used to treat horses, but which must have been cleared from the horse’s system by the time of competition. Banned (doping) Substances should never be found in the body of the horse. In the case of an adverse analytical finding (AAF) for a Banned Substance, the Person Responsible (PR) is automatically provisionally suspended from the date of notification (with the exception of certain cases involving a Banned Substance which is also a **Specified Substance). The horse is suspended for two months. Information on all substances is available on the searchable FEI Equine Prohibited Substances Database.

**Specified Substances

The FEI introduced the concept of Specified Substances in 2016. Specified Substances should not in any way be considered less important or less dangerous than other Prohibited Substances (i.e. whether Banned or Controlled). Rather, they are simply substances which are more likely to have been ingested by horses for a purpose other than the enhancement of sport performance, for example, through a contaminated food substance.